FMC Corp. on March 12 announced a collaboration in Canada with biosolutions provider Novonesis (formerly Novozymes A/S). The agreement is part of FMC’s strategic plan to grow its biologicals platform in key markets.
Beginning June 1, 2024, FMC Canada will be the exclusive distributor of Novonesis’ biosolution products for the 2025 growing season, including brands TagTeam®, Optimize®, JumpStart®, BioniQ®, Cell-Tech®, and Nitragin®. Additionally, the companies will utilize their respective R&D capabilities to collaborate on the development of novel biological technology for Canadian farmers.
The partnership will leverage Novonesis’ Plant Biosolutions Manufacturing and Research site in Saskatoon, Sask., and FMC’s market knowledge and expertise in applying biologicals in an integrated approach with synthetic crop protection chemistry and precision agriculture technology. Terms of the commercial agreement were not disclosed.
FMC said it has launched approximately 40 biological products – including Accudo® biostimulant, Provilar® biofungicide, and Avodigen® seed treatment – in 24 countries over the past five years and is one of the few companies with a fully global presence.